Clinical Trial: A Study to Evaluate the Efficacy and Safety of Rozanoloxizumab in Adult Participants With Ocular Myasthenia Gravis

U.S., March 12 -- ClinicalTrials.gov registry received information related to the study (NCT07463521) titled 'A Study to Evaluate the Efficacy and Safety of Rozanoloxizumab in Adult Participants With Ocular Myasthenia Gravis' on March 05.

Brief Summary: The purpose of the study is to demonstrate the efficacy, safety and tolerability of rozanolixizumab compared with placebo in the treatment of adult study participants with Ocular Myasthenia Gravis.

Study Start Date: May 29

Study Type: INTERVENTIONAL

Condition: Ocular Myasthenia Gravis

Intervention: DRUG: Rozanolixizumab

Rozanolixizumab will be administered by subcutaneous infusion.

DRUG: Placebo

Placebo will be administered by subcutaneous infusion.

Recruitment Status: NOT_YET_REC...